Abstract: An immobilized polypeptide including a polypeptide bound to a surface of a polypeptide array or a chip, wherein the polypeptide has the amino acid sequence of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:1 lacking the N-terminal methionine, SEQ ID NO:3 lacking the N-terminal methionine, or a combination thereof.

Abstract: A system (1) comprises an aspiration catheter (2), which is guided by way of a guidewire (3) to a thrombotic point in a blood vessel. A collapsed infusion balloon (4) is located inside the aspiration catheter (2), which has an interior/inner volume (40) delimited by a wall (41), and a delivery catheter (42). The delivery catheter 42 is intended for delivering saline solution (salt solution) for rinsing or for delivering thrombolytic medication into the interior 40. The balloon comprises a plurality of openings which have a diameter between 10 ?m and 100 ?m in order to enable an atraumatic administration of fluid.

Abstract: An immobilized polypeptide including a polypeptide bound to a surface of a polypeptide array or a chip, wherein the polypeptide has the amino acid sequence of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:1 lacking the N-terminal methionine, SEQ ID NO:3 lacking the N-terminal methionine, or a combination thereof.

Abstract: A polypeptide containing an amino acid sequence having at least 60% identity to the amino acid sequence SEQ ID No. 1 or containing at least one amino acid fragment of at least 6 consecutive amino acid residues of the amino acid sequence SEQ ID No. 1 or having immunological cross-reactivity to the amino acid sequence SEQ ID No. 1 or fragments thereof, wherein the amino acid sequence SEQ ID No. 1 codes for an allergen and the polypeptide comprises at least one T cell epitope recognized by a T cell receptor specific for a molecule having the amino acid sequence SEQ ID No. 1.

Abstract: The invention relates to an allergy test chamber comprising at least one inlet for supplying allergen-free air, especially fresh air, into the chamber. Said chamber is characterised in that the at least one inlet (23) for allergen-free air is provided with an air flow distribution device (26, 27), and in that the allergy test chamber (20) also comprises at least one inlet (25) for allergen test particles, such as plant pollen or mite faeces, and at least one outlet (24) for removing air loaded with allergen test particles from the chamber by means of suction. Said outlet (24) is arranged at a distance from the inlets (23, 25) for allergen-free air and allergen test particles. Said air movement principle i.e.

Abstract: A polypeptide comprising an amino acid sequence having at least 60% identity to the amino acid sequence SEQ ID No. 1 or comprising at least one amino acid fragment of at least 6 consecutive amino acid residues of the amino acid sequence SEQ ID No. 1 or having immunological cross-reactivity to the amino acid sequence SEQ ID No. 1 or fragments thereof, wherein the amino acid sequence SEQ ID No. 1 codes for an allergen and the polypeptide comprises at least one T cell epitope recognized by a T cell receptor specific for a molecule having the amino acid sequence SEQ ID No. 1.

Abstract: The invention relates to an allergy test chamber comprising at least one inlet for supplying allergen-free air, especially fresh air, into the chamber. Said chamber is characterised in that the at least one inlet (23) for allergen-free air is provided with an air flow distribution device (26, 27), and in that the allergy test chamber (20) also comprises at least one inlet (25) for allergen test particles, such as plant pollen or mite faeces, and at least one outlet (24) for removing air loaded with allergen test particles from the chamber by means of suction. Said outlet (24) is arranged at a distance from the inlets (23, 25) for allergen-free air and allergen test particles. Said air movement principle i.e.